From: RVS22@JPNAIST.BITNET ("RVS22@JPNAIST ANDREAS,TSUKUBA/JAPA")
Newsgroups: bionet.general
Subject: (COPY) Undeliverable Mail
Date: 6 Oct 92 14:15:00 GMT
Distribution: bionet




-------------------------TEXT-OF-FORWARDED-MAIL--------------------------------

Received: (from VMMAIL@PUCC for RVS22@JPNAIST via NJE)
 (UCLA/Mail V1.410 M-RSCS8135-8135-81); Mon, 05 Oct 92 18:02:15 JST
Received: from PUCC by PUCC.PRINCETON.EDU (Mailer R2.08 ptf043) with BSMTP id
 1935; Sun, 04 Oct 92 12:14:38 EDT
Date: Sun, 04 Oct 92 12:14:35 EDT
From: <SMTPC@PUCC.PRINCETON.EDU>
To: <RVS22>
Subject: Undeliverable Mail

pucc.Princeton.EDU unable to deliver following mail to recipient(s):
    <COMP-BIO@GENBANK.BIO.NET>
pucc.Princeton.EDU unable to connect for 3 days to recipient host.

           ** Text of Mail follows **
Received: from PUCC.PRINCETON.EDU by pucc.Princeton.EDU (IBM VM SMTP V2R2)
   with BSMTP id 6601; Thu, 01 Oct 92 12:06:47 EDT
Received: from JPNAIST.BITNET (RVS22) by PUCC.PRINCETON.EDU (Mailer R2.09
 ptf004) with BSMTP id 3984; Thu, 01 Oct 92 11:48:51 EDT
Date:    Thu, 01 Oct 92 21:01 JST
To:      COMP-BIO@GENBANK.BIO.NET
From:    "RVS22@JPNAIST ANDREAS,TSUKUBA/JAPA"
 <RVS22%JPNAIST.BITNET@pucc.Princeton.EDU>
Subject: (COPY) Re: MODELLING & SIMMULATION OF HRG




-------------------------TEXT-OF-FORWARDED-MAIL--------------------------------

Received: (from GS.NET@STANFORD for RVS22@JPNAIST via NJE)
 (UCLA/Mail V1.410 M-NETMAIL-5094-52); Thu, 01 Oct 92 20:40:05 JST
Received: by Forsythe.Stanford.EDU; Wed, 30 Sep 92 23:21:46 PDT
Received: by net.bio.net (5.65/IG-2.0)
        id AA14324; Wed, 30 Sep 92 23:14:18 -0700
Date: Wed, 30 Sep 92 23:14:17 PDT
From: Dave Kristofferson <kristoff@NET.BIO.NET>
To: "RVS22@JPNAIST ANDREAS,TSUKUBA/JAPA" <RVS22>
Subject: Re: MODELLING & SIMMULATION OF HRG
Message-Id: <CMM.0.90.2.717920057.kristoff@net.bio.net>

> DEAR BIOSCI,
>
> PLEASE RESPOND:
>
> 1.I'M DOING RESEARCH WITH HUMAN HISTIDINE RICH GLYCOPROTEIN(HHRG)
> 2.HOW TO OBTAIN THE DATABANK ENTRIES(GENBANK,PIR, ETC) FOR THE HHRG
> AND THE CORRESPONDING GENE.
> 3.HHRG IS A MULTIFUNCTIONAL PROTEIN WITH MANY UNCERTAIN ATTRIBUTES WHICH
> SHOULD BE ELUCIDATED.
> 4.I AM AN M.D. AND AM SHYING OF CLASSICAL BENCHWORK DUE TO ITS TEDIUM, AND
>   THUS SWITCH TO HIGH PERFORMANCE COMPUTING & COMMUNICATION RESOURCES TO
> ANALYSE THESE TWO SEQUENCES ACCROSS THE BOARD.
> 5.I'M WORKING ON THE ARTIFICIAL BLOOD WESSEL PROJECT LOUNCHED BY THE
> MINISTRY OF INTERNATL TRADE AND IND(MITI).  THE BASIC IDEA IS TO
> BLOCK TROMBOGENIC ATTRIBUTS OF VESSEL GRAFTS.  COVERING OF AN
> ARTIFICIAL POLYMER BY HHRGP SHOULD REDUCE DEVICE THROMBOGENICITY.
> TO TEST THIS YOU NEED CCA. 1 MONTH.
> SINCE THIS IS A PROBLEM CONSISTING OF A.VESSEL WALL, B.HHRP COATING
> A0D C.BLOODFLOW, I'M THINKING TO MODELL THIS SYSTEM: BLOODFLOW
> IN VS.  SPECIAL VESSEL WALL.  COULD I PLEASE HAVE THE ASSISTANCE OF
> RESEARCHERS HAVING MORE EXPERIENCE IN THIS FIELD?
>
> THANKS & BEST REGARDS
>
> DR.ANDREAS D.PERICH
> MITI LABS/PALACE MIKI        RVS22@JPNAIST
> 2-29-22-202 HIGASHI
> TSUKUBA 305   J A P A N
>
>
>
>

You should mail this to bioforum@net.bio.net.  The biosci@net.bio.net
address is used only for requesting subscriptions.

                                Sincerely,

                                Dave Kristofferson
                                BIOSCI/bionet Manager

                                kristoff@net.bio.net
Newsgroups: bionet.general